Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

English (EN)·Polski (PL)·Ukraiński (UK)
Przejdź do strony domowej biblioteki Uniwersytet Ekonomiczny we Wrocławiu Link otwiera się w nowym oknie Logo biblioteki Prolib Integro - strona głównaUniwersytet Ekonomiczny we Wrocławiu

Wyszukujesz frazę ""Heemskerk-Gerritsen BAM"" wg kryterium: Autor

  Lista filtrów
Wyrównaj
    Wyświetlanie 1-9 z 9
    Tytuł:
    Expression and Localization of Ferritin-Heavy Chain Predicts Recurrence for Breast Cancer Patients with a BRCA1/2 Mutation.
    Autorzy:
    Qu S; Department of Medical Oncology, Erasmus MC Cancer Institute, Erasmus University Medical Center, 3015 GD Rotterdam, The Netherlands.
    Timmermans AM; Department of Medical Oncology, Erasmus MC Cancer Institute, Erasmus University Medical Center, 3015 GD Rotterdam, The Netherlands.
    Heemskerk-Gerritsen BAM; Department of Medical Oncology, Erasmus MC Cancer Institute, Erasmus University Medical Center, 3015 GD Rotterdam, The Netherlands.
    Trapman-Jansen AMAC; Department of Medical Oncology, Erasmus MC Cancer Institute, Erasmus University Medical Center, 3015 GD Rotterdam, The Netherlands.
    Broeren-Foekens R; Department of Medical Oncology, Erasmus MC Cancer Institute, Erasmus University Medical Center, 3015 GD Rotterdam, The Netherlands.
    Prager-van der Smissen WJC; Department of Medical Oncology, Erasmus MC Cancer Institute, Erasmus University Medical Center, 3015 GD Rotterdam, The Netherlands.
    El Hassnaoui H; Department of Medical Oncology, Erasmus MC Cancer Institute, Erasmus University Medical Center, 3015 GD Rotterdam, The Netherlands.
    van Tienhoven T; Department of Medical Oncology, Erasmus MC Cancer Institute, Erasmus University Medical Center, 3015 GD Rotterdam, The Netherlands.
    Bes-Stobbe CK; Pathan BV, Kleiweg 500, 3045 PM Rotterdam, The Netherlands.
    Westenend PJ; Laboratory of Pathology, 3318 AL Dordrecht, The Netherlands.
    van Deurzen CHM; Department of Pathology, Erasmus University Medical Center, 3000 CA Rotterdam, The Netherlands.
    Martens JWM; Department of Medical Oncology, Erasmus MC Cancer Institute, Erasmus University Medical Center, 3015 GD Rotterdam, The Netherlands.
    Hooning MJ; Department of Medical Oncology, Erasmus MC Cancer Institute, Erasmus University Medical Center, 3015 GD Rotterdam, The Netherlands.
    Hollestelle A; Department of Medical Oncology, Erasmus MC Cancer Institute, Erasmus University Medical Center, 3015 GD Rotterdam, The Netherlands.
    Pokaż więcej
    Źródło:
    Cancers [Cancers (Basel)] 2023 Dec 20; Vol. 16 (1). Date of Electronic Publication: 2023 Dec 20.
    Typ publikacji:
    Journal Article
    Czasopismo naukowe
    Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
    Tytuł:
    Risk of metachronous contralateral breast cancer in patients with primary invasive lobular breast cancer: Results from a nationwide cohort.
    Autorzy:
    Akdeniz D; Department of Medical Oncology, Erasmus MC Cancer Institute, Rotterdam, the Netherlands.
    Kramer I; Division of Psychosocial Research and Epidemiology, Netherlands Cancer Institute, Amsterdam, the Netherlands.; Division of Molecular Pathology, Netherlands Cancer Institute, Amsterdam, the Netherlands.
    van Deurzen CHM; Department of Pathology, Erasmus MC, Rotterdam, the Netherlands.
    Heemskerk-Gerritsen BAM; Department of Medical Oncology, Erasmus MC Cancer Institute, Rotterdam, the Netherlands.
    Schaapveld M; Division of Psychosocial Research and Epidemiology, Netherlands Cancer Institute, Amsterdam, the Netherlands.
    Westenend PJ; Department of Pathology, Albert Schweitzer Hospital, Dordrecht, the Netherlands.
    Voogd AC; Department of Research and Development, Netherlands Comprehensive Cancer Organization (IKNL), Utrecht, the Netherlands.; Department of Epidemiology, Maastricht University, Maastricht, the Netherlands.
    Jager A; Department of Medical Oncology, Erasmus MC Cancer Institute, Rotterdam, the Netherlands.
    Steyerberg EW; Department of Public Health, Erasmus MC, Rotterdam, the Netherlands.; Department of Biomedical Data Sciences, Leiden University Medical Centre, Leiden, the Netherlands.
    Sleijfer S; Department of Medical Oncology, Erasmus MC Cancer Institute, Rotterdam, the Netherlands.
    Schmidt MK; Division of Psychosocial Research and Epidemiology, Netherlands Cancer Institute, Amsterdam, the Netherlands.; Division of Molecular Pathology, Netherlands Cancer Institute, Amsterdam, the Netherlands.
    Hooning MJ; Department of Medical Oncology, Erasmus MC Cancer Institute, Rotterdam, the Netherlands.
    Pokaż więcej
    Źródło:
    Cancer medicine [Cancer Med] 2023 Feb; Vol. 12 (3), pp. 3123-3133. Date of Electronic Publication: 2022 Sep 20.
    Typ publikacji:
    Journal Article; Research Support, Non-U.S. Gov't
    MeSH Terms:
    Breast Neoplasms*/pathology
    Carcinoma, Ductal, Breast*/pathology
    Carcinoma, Lobular*/pathology
    Neoplasms, Second Primary*/epidemiology
    Humans ; Female ; Prognosis ; Risk Factors
    Czasopismo naukowe
    Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
    Tytuł:
    Progression-free survival and overall survival after BRCA1/2-associated epithelial ovarian cancer: A matched cohort study.
    Autorzy:
    Heemskerk-Gerritsen BAM; Department of Medical Oncology, Erasmus MC Cancer Institute, Rotterdam, the Netherlands.
    Hollestelle A; Department of Medical Oncology, Erasmus MC Cancer Institute, Rotterdam, the Netherlands.
    van Asperen CJ; Department of Clinical Genetics, Leiden University Medical Center, Leiden, the Netherlands.
    van den Beek I; Department of Human Genetics, Amsterdam University Medical Center (University of Amsterdam), Amsterdam, the Netherlands.
    van Driel WJ; Department of Gynecology, Netherlands Cancer Institute, Amsterdam, the Netherlands.
    van Engelen K; Department of Clinical Genetics, Amsterdam University Medical Center (VUmc), Amsterdam, the Netherlands.
    Gómez Garcia EB; Department of Clinical Genetics, Maastricht University Medical Center, Maastricht, the Netherlands.
    de Hullu JA; Department of Obstetrics & Gynecology, Radboud University Medical Center, Nijmegen, the Netherlands.
    Koudijs MJ; Department of Biomedical Genetics, Utrecht University Medical Center, Utrecht, the Netherlands.
    Mourits MJE; Department of Gynecologic Oncology, University Medical Center Groningen, Groningen, the Netherlands.
    Hooning MJ; Department of Medical Oncology, Erasmus MC Cancer Institute, Rotterdam, the Netherlands.
    Boere IA; Department of Medical Oncology, Erasmus MC Cancer Institute, Rotterdam, the Netherlands.
    Pokaż więcej
    Źródło:
    PloS one [PLoS One] 2022 Sep 22; Vol. 17 (9), pp. e0275015. Date of Electronic Publication: 2022 Sep 22 (Print Publication: 2022).
    Typ publikacji:
    Journal Article; Research Support, Non-U.S. Gov't
    MeSH Terms:
    Genes, BRCA1*
    Ovarian Neoplasms*/diagnosis
    Ovarian Neoplasms*/drug therapy
    Ovarian Neoplasms*/genetics
    BRCA1 Protein/genetics ; BRCA2 Protein/genetics ; Carcinoma, Ovarian Epithelial/drug therapy ; Carcinoma, Ovarian Epithelial/genetics ; Cohort Studies ; Female ; Germ-Line Mutation ; Humans ; Progression-Free Survival
    Czasopismo naukowe
    Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
    Tytuł:
    HER2-low breast cancer shows a lower immune response compared to HER2-negative cases.
    Autorzy:
    van den Ende NS; Department of Pathology, Erasmus MC Cancer Institute, Erasmus University Medical Centre, 's-Gravendijkwal 230, 3015 CE, Rotterdam, The Netherlands.
    Smid M; Department of Medical Oncology, Erasmus MC Cancer Institute, Erasmus University Medical Centre, Rotterdam, The Netherlands.
    Timmermans A; Department of Medical Oncology, Erasmus MC Cancer Institute, Erasmus University Medical Centre, Rotterdam, The Netherlands.
    van Brakel JB; Department of Pathology, Erasmus MC Cancer Institute, Erasmus University Medical Centre, 's-Gravendijkwal 230, 3015 CE, Rotterdam, The Netherlands.; Department of Pathology, Skåne University Hospital, Malmö, Sweden.
    Hansum T; Department of Pathology, Erasmus MC Cancer Institute, Erasmus University Medical Centre, 's-Gravendijkwal 230, 3015 CE, Rotterdam, The Netherlands.; Department of Pathology, Reinier Haga MDC, Delft, The Netherlands.
    Foekens R; Department of Medical Oncology, Erasmus MC Cancer Institute, Erasmus University Medical Centre, Rotterdam, The Netherlands.
    Trapman AMAC; Department of Medical Oncology, Erasmus MC Cancer Institute, Erasmus University Medical Centre, Rotterdam, The Netherlands.
    Heemskerk-Gerritsen BAM; Department of Medical Oncology, Erasmus MC Cancer Institute, Erasmus University Medical Centre, Rotterdam, The Netherlands.
    Jager A; Department of Medical Oncology, Erasmus MC Cancer Institute, Erasmus University Medical Centre, Rotterdam, The Netherlands.
    Martens JWM; Department of Medical Oncology, Erasmus MC Cancer Institute, Erasmus University Medical Centre, Rotterdam, The Netherlands.
    van Deurzen CHM; Department of Pathology, Erasmus MC Cancer Institute, Erasmus University Medical Centre, 's-Gravendijkwal 230, 3015 CE, Rotterdam, The Netherlands. .
    Pokaż więcej
    Źródło:
    Scientific reports [Sci Rep] 2022 Jul 28; Vol. 12 (1), pp. 12974. Date of Electronic Publication: 2022 Jul 28.
    Typ publikacji:
    Journal Article; Research Support, Non-U.S. Gov't
    MeSH Terms:
    Breast Neoplasms*/pathology
    Biomarkers, Tumor/metabolism ; Female ; Humans ; Immunity ; Immunohistochemistry ; Receptor, ErbB-2/metabolism ; Receptors, Estrogen/genetics ; Receptors, Estrogen/metabolism ; Receptors, Progesterone
    Czasopismo naukowe
    Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
    Tytuł:
    Germline variants and breast cancer survival in patients with distant metastases at primary breast cancer diagnosis.
    Autorzy:
    Escala-Garcia M; Division of Molecular Pathology, The Netherlands Cancer Institute-Antoni Van Leeuwenhoek Hospital, Amsterdam, The Netherlands.
    Canisius S; Division of Molecular Pathology, The Netherlands Cancer Institute-Antoni Van Leeuwenhoek Hospital, Amsterdam, The Netherlands.; Division of Molecular Carcinogenesis, The Netherlands Cancer Institute-Antoni Van Leeuwenhoek Hospital, Amsterdam, The Netherlands.
    Keeman R; Division of Molecular Pathology, The Netherlands Cancer Institute-Antoni Van Leeuwenhoek Hospital, Amsterdam, The Netherlands.
    Beesley J; Department of Genetics and Computational Biology, QIMR Berghofer Medical Research Institute, Brisbane, QLD, Australia.
    Anton-Culver H; Department of Medicine, Genetic Epidemiology Research Institute, University of California Irvine, Irvine, CA, USA.
    Arndt V; Division of Clinical Epidemiology and Aging Research, German Cancer Research Center (DKFZ), Heidelberg, Germany.
    Augustinsson A; Department of Cancer Epidemiology, Clinical Sciences, Lund University, Lund, Sweden.
    Becher H; Institute of Medical Biometry and Epidemiology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
    Beckmann MW; Department of Gynecology and Obstetrics, Comprehensive Cancer Center Erlangen-EMN, University Hospital Erlangen, Friedrich-Alexander University Erlangen-Nuremberg (FAU), Erlangen, Germany.
    Behrens S; Division of Cancer Epidemiology, German Cancer Research Center (DKFZ), Heidelberg, Germany.
    Bermisheva M; Institute of Biochemistry and Genetics, Ufa Federal Research Centre of the Russian Academy of Sciences, Ufa, Russia.
    Bojesen SE; Copenhagen University Hospital, Copenhagen General Population Study, Herlev, Denmark.; Gentofte Hospital, Herlev, Denmark.; Department of Clinical Biochemistry, Copenhagen University Hospital, Herlev, Denmark.; Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark.
    Bolla MK; Department of Public Health and Primary Care, Centre for Cancer Genetic Epidemiology, University of Cambridge, Cambridge, UK.
    Brenner H; Division of Clinical Epidemiology and Aging Research, German Cancer Research Center (DKFZ), Heidelberg, Germany.; Division of Preventive Oncology, German Cancer Research Center (DKFZ) and National Center for Tumor Diseases (NCT), Heidelberg, Germany.; German Cancer Research Center (DKFZ), German Cancer Consortium (DKTK), Heidelberg, Germany.
    Canzian F; Genomic Epidemiology Group, German Cancer Research Center (DKFZ), Heidelberg, Germany.
    Castelao JE; Instituto de Investigación Sanitaria Galicia Sur (IISGS), Xerencia de Xestion Integrada de Vigo-SERGAS, Oncology and Genetics Unit, Vigo, Spain.
    Chang-Claude J; Division of Cancer Epidemiology, German Cancer Research Center (DKFZ), Heidelberg, Germany.; University Medical Center Hamburg-Eppendorf, Cancer Epidemiology Group, University Cancer Center Hamburg (UCCH), Hamburg, Germany.
    Chanock SJ; Division of Cancer Epidemiology and Genetics, Department of Health and Human Services, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA.
    Couch FJ; Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN, USA.
    Czene K; Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden.
    Daly MB; Department of Clinical Genetics, Fox Chase Cancer Center, Philadelphia, PA, USA.
    Dennis J; Department of Public Health and Primary Care, Centre for Cancer Genetic Epidemiology, University of Cambridge, Cambridge, UK.
    Devilee P; Department of Pathology, Leiden University Medical Center, Leiden, The Netherlands.; Department of Human Genetics, Leiden University Medical Center, Leiden, The Netherlands.
    Dörk T; Gynaecology Research Unit, Hannover Medical School, Hannover, Germany.
    Dunning AM; Department of Oncology, Centre for Cancer Genetic Epidemiology, University of Cambridge, Cambridge, UK.
    Easton DF; Department of Public Health and Primary Care, Centre for Cancer Genetic Epidemiology, University of Cambridge, Cambridge, UK.; Department of Oncology, Centre for Cancer Genetic Epidemiology, University of Cambridge, Cambridge, UK.
    Ekici AB; Institute of Human Genetics, Comprehensive Cancer Center Erlangen-EMN, University Hospital Erlangen, Friedrich-Alexander University Erlangen-Nuremberg (FAU), Erlangen, Germany.
    Eliassen AH; Channing Division of Network Medicine, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, USA.; Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, MA, USA.
    Fasching PA; Department of Gynecology and Obstetrics, Comprehensive Cancer Center Erlangen-EMN, University Hospital Erlangen, Friedrich-Alexander University Erlangen-Nuremberg (FAU), Erlangen, Germany.; Division of Hematology and Oncology, Department of Medicine, David Geffen School of Medicine, University of California at Los Angeles, Los Angeles, CA, USA.
    Flyger H; Department of Breast Surgery, Copenhagen University Hospital, Herlev, Denmark.
    Gago-Dominguez M; Instituto de Investigación Sanitaria de Santiago de Compostela (IDIS), Complejo Hospitalario Universitario de Santiago, SERGAS, Fundación Pública Galega de Medicina Xenómica, Santiago de Compostela, Spain.; Moores Cancer Center, University of California San Diego, La Jolla, CA, USA.
    García-Closas M; Division of Cancer Epidemiology and Genetics, Department of Health and Human Services, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA.
    García-Sáenz JA; Instituto de Investigación Sanitaria San Carlos (IdISSC), Centro Investigación Biomédica en Red de Cáncer (CIBERONC), Medical Oncology Department, Hospital Clínico San Carlos, Madrid, Spain.
    Geisler J; Department of Oncology, Akershus University Hospital, Lørenskog, Norway.
    Giles GG; Cancer Council Victoria, Cancer Epidemiology Division, Melbourne, VIC, Australia.; Melbourne School of Population and Global Health, Centre for Epidemiology and Biostatistics, The University of Melbourne, Melbourne, VIC, Australia.; Precision Medicine, School of Clinical Sciences at Monash Health, Monash University, Clayton, VIC, Australia.
    Grip M; Department of Surgery, Oulu University Hospital, University of Oulu, Oulu, Finland.
    Gündert M; German Cancer Research Center (DKFZ), Molecular Epidemiology Group, C080, Heidelberg, Germany.; Molecular Biology of Breast Cancer, University Womens Clinic Heidelberg, University of Heidelberg, Heidelberg, Germany.; Helmholtz Zentrum München, Institute of Diabetes Research, German Research Center for Environmental Health, Neuherberg, Germany.
    Hahnen E; Center for Familial Breast and Ovarian Cancer, Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, Germany.; Center for Integrated Oncology (CIO), Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, Germany.
    Haiman CA; Department of Preventive Medicine, Keck School of Medicine, University of Southern California, Los Angeles, CA, USA.
    Håkansson N; Institute of Environmental Medicine, Karolinska Institutet, Stockholm, Sweden.
    Hall P; Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden.; Department of Oncology, Sšdersjukhuset, Stockholm, Sweden.
    Hamann U; German Cancer Research Center (DKFZ), Molecular Genetics of Breast Cancer, Heidelberg, Germany.
    Hartikainen JM; Translational Cancer Research Area, University of Eastern Finland, Kuopio, Finland.; Institute of Clinical Medicine, Pathology and Forensic Medicine, University of Eastern Finland, Kuopio, Finland.
    Heemskerk-Gerritsen BAM; Department of Medical Oncology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands.
    Hollestelle A; Department of Medical Oncology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands.
    Hoppe R; Dr. Margarete Fischer-Bosch-Institute of Clinical Pharmacology, Stuttgart, Germany.; University of Tübingen, Tübingen, Germany.
    Hopper JL; Melbourne School of Population and Global Health, Centre for Epidemiology and Biostatistics, The University of Melbourne, Melbourne, VIC, Australia.
    Hunter DJ; Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, MA, USA.; Nuffield Department of Population Health, University of Oxford, Oxford, UK.
    Jacot W; Institut du Cancer de Montpellier, Montpellier University, Montpellier, France.
    Jakubowska A; Department of Genetics and Pathology, Pomeranian Medical University, Szczecin, Poland.; Independent Laboratory of Molecular Biology and Genetic Diagnostics, Pomeranian Medical University, Szczecin, Poland.
    John EM; Division of Oncology, Department of Medicine, Stanford University School of Medicine, Stanford Cancer Institute, Stanford, CA, USA.; Department of Epidemiology & Population Health, Stanford University School of Medicine, Stanford, CA, USA.
    Jung AY; Division of Cancer Epidemiology, German Cancer Research Center (DKFZ), Heidelberg, Germany.
    Kaaks R; Division of Cancer Epidemiology, German Cancer Research Center (DKFZ), Heidelberg, Germany.
    Khusnutdinova E; Institute of Biochemistry and Genetics, Ufa Federal Research Centre of the Russian Academy of Sciences, Ufa, Russia.; Department of Genetics and Fundamental Medicine, Bashkir State University, Ufa, Russia.
    Koppert LB; Department of Surgical Oncology, Family Cancer Clinic, Erasmus MC Cancer Institute, Rotterdam, The Netherlands.
    Kraft P; Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, MA, USA.; Harvard T.H. Chan School of Public Health, Program in Genetic Epidemiology and Statistical Genetics, Boston, MA, USA.
    Kristensen VN; Department of Medical Genetics, Oslo University Hospital and University of Oslo, Oslo, Norway.
    Kurian AW; Division of Oncology, Department of Medicine, Stanford University School of Medicine, Stanford Cancer Institute, Stanford, CA, USA.; Department of Epidemiology & Population Health, Stanford University School of Medicine, Stanford, CA, USA.
    Lambrechts D; VIB Center for Cancer Biology, Leuven, Belgium.; Laboratory for Translational Genetics, Department of Human Genetics, University of Leuven, Leuven, Belgium.
    Le Marchand L; University of Hawaii Cancer Center, Epidemiology Program, Honolulu, HI, USA.
    Lindblom A; Department of Molecular Medicine and Surgery, Karolinska Institutet, Stockholm, Sweden.; Department of Clinical Genetics, Karolinska University Hospital, Stockholm, Sweden.
    Luben RN; NIHR Biomedical Research Centre, Moorfields Eye Hospital NHS Foundation Trust and UCL Institute of Ophthalmology, London, England, UK.; Medical Research Council (MRC) Epidemiology Unit, University of Cambridge, Cambridge, UK.
    Lubiński J; Department of Genetics and Pathology, Pomeranian Medical University, Szczecin, Poland.
    Mannermaa A; Translational Cancer Research Area, University of Eastern Finland, Kuopio, Finland.; Institute of Clinical Medicine, Pathology and Forensic Medicine, University of Eastern Finland, Kuopio, Finland.; Kuopio University Hospital, Biobank of Eastern Finland, Kuopio, Finland.
    Manoochehri M; German Cancer Research Center (DKFZ), Molecular Genetics of Breast Cancer, Heidelberg, Germany.
    Margolin S; Department of Oncology, Sšdersjukhuset, Stockholm, Sweden.; Department of Clinical Science and Education, Karolinska Institutet, Sšdersjukhuset, Stockholm, Sweden.
    Mavroudis D; Department of Medical Oncology, University Hospital of Heraklion, Heraklion, Greece.
    Muranen TA; Department of Obstetrics and Gynecology, Helsinki University Hospital, University of Helsinki, Helsinki, Finland.
    Nevanlinna H; Department of Obstetrics and Gynecology, Helsinki University Hospital, University of Helsinki, Helsinki, Finland.
    Olshan AF; Department of Epidemiology, Gillings School of Global Public Health and UNC Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.
    Olsson H; Department of Cancer Epidemiology, Clinical Sciences, Lund University, Lund, Sweden.
    Park-Simon TW; Gynaecology Research Unit, Hannover Medical School, Hannover, Germany.
    Patel AV; Department of Population Science, American Cancer Society, Atlanta, GA, USA.
    Peterlongo P; IFOM-The FIRC Institute of Molecular Oncology, Genome Diagnostics Program, Milan, Italy.
    Pharoah PDP; Department of Public Health and Primary Care, Centre for Cancer Genetic Epidemiology, University of Cambridge, Cambridge, UK.; Department of Oncology, Centre for Cancer Genetic Epidemiology, University of Cambridge, Cambridge, UK.
    Punie K; Department of General Medical Oncology and Multidisciplinary Breast Centre, Leuven Cancer Institute, University Hospitals Leuven, Leuven, Belgium.
    Radice P; Unit of Molecular Bases of Genetic Risk and Genetic Testing, Department of Research, Fondazione IRCCS Istituto Nazionale dei Tumori (INT), Milan, Italy.
    Rennert G; Carmel Medical Center and Technion Faculty of Medicine, Clalit National Cancer Control Center, Haifa, Israel.
    Rennert HS; Carmel Medical Center and Technion Faculty of Medicine, Clalit National Cancer Control Center, Haifa, Israel.
    Romero A; Medical Oncology Department, Hospital Universitario Puerta de Hierro, Madrid, Spain.
    Roylance R; Department of Oncology, UCLH Foundation Trust, London, UK.
    Rüdiger T; Institute of Pathology, Staedtisches Klinikum Karlsruhe, Karlsruhe, Germany.
    Ruebner M; Department of Gynecology and Obstetrics, Comprehensive Cancer Center Erlangen-EMN, University Hospital Erlangen, Friedrich-Alexander University Erlangen-Nuremberg (FAU), Erlangen, Germany.
    Saloustros E; Department of Oncology, University Hospital of Larissa, Larissa, Greece.
    Sawyer EJ; School of Cancer & Pharmaceutical Sciences, Comprehensive Cancer Centre, King's College London, Guy's Campus, London, UK.
    Schmutzler RK; Center for Familial Breast and Ovarian Cancer, Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, Germany.; Center for Integrated Oncology (CIO), Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, Germany.; Center for Molecular Medicine Cologne (CMMC), Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, Germany.
    Schoemaker MJ; Division of Genetics and Epidemiology, The Institute of Cancer Research, London, UK.
    Scott C; Department of Health Sciences Research, Mayo Clinic, Rochester, MN, USA.
    Southey MC; Cancer Council Victoria, Cancer Epidemiology Division, Melbourne, VIC, Australia.; Precision Medicine, School of Clinical Sciences at Monash Health, Monash University, Clayton, VIC, Australia.; Department of Clinical Pathology, The University of Melbourne, Melbourne, Victoria, Australia.
    Surowy H; German Cancer Research Center (DKFZ), Molecular Epidemiology Group, C080, Heidelberg, Germany.; Molecular Biology of Breast Cancer, University Womens Clinic Heidelberg, University of Heidelberg, Heidelberg, Germany.
    Swerdlow AJ; Division of Genetics and Epidemiology, The Institute of Cancer Research, London, UK.; Division of Breast Cancer Research, The Institute of Cancer Research, London, UK.
    Tamimi RM; Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, MA, USA.; Department of Population Health Sciences, Weill Cornell Medicine, New York, NY, USA.
    Teras LR; Department of Population Science, American Cancer Society, Atlanta, GA, USA.
    Thomas E; Plateforme de Bioinformatique Gilles Thomas, Centre de recherche en cancérologie de Lyon, Fondation Synergie Lyon Cancer, Université Claude Bernard Lyon 1, Lyon, France.
    Tomlinson I; Institute of Cancer and Genomic Sciences, University of Birmingham, Birmingham, UK.; Wellcome Trust Centre for Human Genetics and Oxford NIHR Biomedical Research Centre, University of Oxford, Oxford, UK.
    Troester MA; Department of Epidemiology, Gillings School of Global Public Health and UNC Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.
    Vachon CM; Division of Epidemiology, Department of Health Science Research, Mayo Clinic, Rochester, MN, USA.
    Wang Q; Department of Public Health and Primary Care, Centre for Cancer Genetic Epidemiology, University of Cambridge, Cambridge, UK.
    Winqvist R; Laboratory of Cancer Genetics and Tumor Biology, Cancer and Translational Medicine Research Unit, University of Oulu, Biocenter Oulu, Oulu, Finland.; Laboratory of Cancer Genetics and Tumor Biology, Northern Finland Laboratory Centre Oulu, Oulu, Finland.
    Wolk A; Institute of Environmental Medicine, Karolinska Institutet, Stockholm, Sweden.; Department of Surgical Sciences, Uppsala University, Uppsala, Sweden.
    Ziogas A; Department of Medicine, Genetic Epidemiology Research Institute, University of California Irvine, Irvine, CA, USA.
    Michailidou K; Department of Public Health and Primary Care, Centre for Cancer Genetic Epidemiology, University of Cambridge, Cambridge, UK.; Biostatistics Unit, The Cyprus Institute of Neurology & Genetics, Nicosia, Cyprus.; Cyprus School of Molecular Medicine, The Cyprus Institute of Neurology & Genetics, Nicosia, Cyprus.
    Chenevix-Trench G; Department of Genetics and Computational Biology, QIMR Berghofer Medical Research Institute, Brisbane, QLD, Australia.
    Bachelot T; Département de Cancérologie Médicale, Centre Léon Bérard, Lyon, France.
    Schmidt MK; Division of Molecular Pathology, The Netherlands Cancer Institute-Antoni Van Leeuwenhoek Hospital, Amsterdam, The Netherlands. .; Division of Psychosocial Research and Epidemiology, The Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands. .
    Pokaż więcej
    Corporate Authors:
    kConFab/AOCS Investigators
    Źródło:
    Scientific reports [Sci Rep] 2021 Oct 05; Vol. 11 (1), pp. 19787. Date of Electronic Publication: 2021 Oct 05.
    Typ publikacji:
    Journal Article; Meta-Analysis; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S.
    MeSH Terms:
    Cancer Survivors*
    Genetic Variation*
    Breast Neoplasms/*genetics
    Breast Neoplasms/*mortality
    Germ Cells/*metabolism
    Biomarkers, Tumor ; Breast Neoplasms/epidemiology ; Breast Neoplasms/pathology ; Female ; Genetic Predisposition to Disease ; Germ-Line Mutation ; Humans ; Kaplan-Meier Estimate ; Polymorphism, Single Nucleotide
    Czasopismo naukowe
    Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
    Tytuł:
    Estrogens and Progestogens in Triple Negative Breast Cancer: Do They Harm?
    Autorzy:
    van Barele M; Department of Medical Oncology, Erasmus MC Cancer Institute, University Medical Centre, Dr. Molewaterplein 40, 3015 GD Rotterdam, The Netherlands.
    Heemskerk-Gerritsen BAM; Department of Medical Oncology, Erasmus MC Cancer Institute, University Medical Centre, Dr. Molewaterplein 40, 3015 GD Rotterdam, The Netherlands.
    Louwers YV; Department of Obstetrics and Gynaecology, Erasmus MC, University Medical Centre, Dr. Molewaterplein 40, 3015 GD Rotterdam, The Netherlands.
    Vastbinder MB; Department of Internal Medicine, Ijsselland Hospital, Prins Constantijnweg 2, 2906 ZC Capelle aan den IJssel, The Netherlands.
    Martens JWM; Department of Medical Oncology, Erasmus MC Cancer Institute, University Medical Centre, Dr. Molewaterplein 40, 3015 GD Rotterdam, The Netherlands.
    Hooning MJ; Department of Medical Oncology, Erasmus MC Cancer Institute, University Medical Centre, Dr. Molewaterplein 40, 3015 GD Rotterdam, The Netherlands.
    Jager A; Department of Medical Oncology, Erasmus MC Cancer Institute, University Medical Centre, Dr. Molewaterplein 40, 3015 GD Rotterdam, The Netherlands.
    Pokaż więcej
    Źródło:
    Cancers [Cancers (Basel)] 2021 May 21; Vol. 13 (11). Date of Electronic Publication: 2021 May 21.
    Typ publikacji:
    Journal Article; Review
    Czasopismo naukowe
    Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
    Tytuł:
    Gene-Environment Interactions Relevant to Estrogen and Risk of Breast Cancer: Can Gene-Environment Interactions Be Detected Only among Candidate SNPs from Genome-Wide Association Studies?
    Autorzy:
    Park J; Department of Biomedical Sciences, Seoul National University Graduate School, Seoul 03080, Korea.; BK21plus Biomedical Science Project, Seoul National University College of Medicine, Seoul 03080, Korea.
    Choi JY; Department of Biomedical Sciences, Seoul National University Graduate School, Seoul 03080, Korea.; BK21plus Biomedical Science Project, Seoul National University College of Medicine, Seoul 03080, Korea.; Institute of Health Policy and Management, Seoul National University Medical Research Center, Seoul 03080, Korea.; Cancer Research Institute, Seoul National University, Seoul 03080, Korea.
    Choi J; Institute of Health Policy and Management, Seoul National University Medical Research Center, Seoul 03080, Korea.
    Chung S; Department of Biomedical Sciences, Seoul National University Graduate School, Seoul 03080, Korea.
    Song N; College of Pharmacy, Chungbuk National University, Cheongju-si 28160, Korea.
    Park SK; Department of Biomedical Sciences, Seoul National University Graduate School, Seoul 03080, Korea.; Cancer Research Institute, Seoul National University, Seoul 03080, Korea.; Department of Preventive Medicine, Seoul National University College of Medicine, Seoul 03080, Korea.
    Han W; Cancer Research Institute, Seoul National University, Seoul 03080, Korea.; Department of Surgery, Seoul National University College of Medicine, Seoul 03080, Korea.
    Noh DY; Cancer Research Institute, Seoul National University, Seoul 03080, Korea.; Department of Surgery, Seoul National University College of Medicine, Seoul 03080, Korea.
    Ahn SH; Department of Surgery, Medicine and ASAN Medical Center, University of Ulsan College, Seoul 05505, Korea.
    Lee JW; Department of Surgery, Medicine and ASAN Medical Center, University of Ulsan College, Seoul 05505, Korea.
    Kim MK; Division of Cancer Epidemiology and Management, National Cancer Center, Goyang-si 10408, Korea.
    Jee SH; Department of Epidemiology and Health Promotion, Institute for Health Promotion, Graduate School of Public Health, Yonsei University, Seoul 03722, Korea.
    Wen W; Division of Epidemiology, Department of Medicine, Vanderbilt University Medical Center, Nashville, TN 37232, USA.
    Bolla MK; Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge CB2 0SR, UK.
    Wang Q; Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge CB2 0SR, UK.
    Dennis J; Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge CB2 0SR, UK.
    Michailidou K; Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge CB2 0SR, UK.; Biostatistics Unit, The Cyprus Institute of Neurology & Genetics, Nicosia 2371, Cyprus.; Cyprus School of Molecular Medicine, The Cyprus Institute of Neurology & Genetics, Nicosia 23462, Cyprus.
    Shah M; Centre for Cancer Genetic Epidemiology, Department of Oncology, University of Cambridge, Cambridge CB1 8RN, UK.
    Conroy DM; Centre for Cancer Genetic Epidemiology, Department of Oncology, University of Cambridge, Cambridge CB1 8RN, UK.
    Harrington PA; Centre for Cancer Genetic Epidemiology, Department of Oncology, University of Cambridge, Cambridge CB1 8RN, UK.
    Mayes R; Centre for Cancer Genetic Epidemiology, Department of Oncology, University of Cambridge, Cambridge CB1 8RN, UK.
    Czene K; Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, 171 65 Stockholm, Sweden.
    Hall P; Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, 171 65 Stockholm, Sweden.; Department of Oncology, Södersjukhuset, 118 83 Stockholm, Sweden.
    Teras LR; Department of Population Science, American Cancer Society, Atlanta, GA 30303, USA.
    Patel AV; Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN 55905, USA.
    Couch FJ; Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN 55905, USA.
    Olson JE; Department of Health Sciences Research, Mayo Clinic, Rochester, MN 55905, USA.
    Sawyer EJ; School of Cancer & Pharmaceutical Sciences, Comprehensive Cancer Centre, Guy's Campus, King's College London, London SE1 9RT, UK.
    Roylance R; Department of Oncology, UCLH Foundation Trust, London NW1 2PG, UK.
    Bojesen SE; Copenhagen General Population Study, Herlev and Gentofte Hospital, Copenhagen University Hospital, 2730 Herlev, Denmark.; Department of Clinical Biochemistry, Herlev and Gentofte Hospital, Copenhagen University Hospital, 2730 Herlev, Denmark.; Faculty of Health and Medical Sciences, University of Copenhagen, 2200 Copenhagen, Denmark.
    Flyger H; Department of Breast Surgery, Herlev and Gentofte Hospital, Copenhagen University Hospital, 2730 Herlev, Denmark.
    Lambrechts D; VIB Center for Cancer Biology, 3001 Leuve, Belgium.; Laboratory for Translational Genetics, Department of Human Genetics, University of Leuven, 3000 Leuven, Belgium.
    Baten A; Department of Radiotherapy Oncology, KU Leuven-University of Leuven, University Hospitals Leuven, 3000 Leuven, Belgium.
    Matsuo K; Division of Cancer Epidemiology and Prevention, Aichi Cancer Center Research Institute, Nagoya 464-8681, Japan.; Division of Cancer Epidemiology, Nagoya University Graduate School of Medicine, Nagoya 466-8550, Japan.
    Ito H; Division of Cancer Epidemiology, Nagoya University Graduate School of Medicine, Nagoya 466-8550, Japan.
    Guénel P; Center for Research in Epidemiology and Population Health (CESP), Team Exposome and Heredity, INSERM, University Paris-Saclay, 94805 Villejuif, France.
    Truong T; Center for Research in Epidemiology and Population Health (CESP), Team Exposome and Heredity, INSERM, University Paris-Saclay, 94805 Villejuif, France.
    Keeman R; Division of Molecular Pathology, The Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital, 1066 CX Amsterdam, The Netherlands.
    Schmidt MK; Division of Molecular Pathology, The Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital, 1066 CX Amsterdam, The Netherlands.; Division of Psychosocial Research and Epidemiology, The Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital, 1066 CX Amsterdam, The Netherlands.
    Wu AH; Department of Preventive Medicine, Keck School of Medicine, University of Southern California, Los Angeles, CA 90033, USA.
    Tseng CC; Department of Preventive Medicine, Keck School of Medicine, University of Southern California, Los Angeles, CA 90033, USA.
    Cox A; Sheffield Institute for Nucleic Acids (SInFoNiA), Department of Oncology and Metabolism, University of Sheffield, Sheffield S10 2TN, UK.
    Cross SS; Academic Unit of Pathology, Department of Neuroscience, University of Sheffield, Sheffield S10 2TN, UK.
    kConFab Investigators; Peter MacCallum Cancer Center, Melbourne, VIC 3000, Australia.; Sir Peter MacCallum Department of Oncology, The University of Melbourne, Melbourne, VIC 3000, Australia.
    Andrulis IL; Fred A, Litwin Center for Cancer Genetics, Lunenfeld-Tanenbaum Research Institute of Mount Sinai Hospital, Toronto, ON M5G 1X5, Canada.; Department of Molecular Genetics, University of Toronto, Toronto, ON M5S 1A8, Canada.
    Hopper JL; Centre for Epidemiology and Biostatistics, Melbourne School of Population and Global Health, The University of Melbourne, Melbourne, VIC 3010, Australia.
    Southey MC; Precision Medicine, School of Clinical Sciences at Monash Health, Monash University, Clayton, VIC 3168, Australia.; Department of Clinical Pathology, The University of Melbourne, Melbourne, VIC 3010, Australia.; Cancer Epidemiology Division, Cancer Council Victoria, Melbourne, VIC 3004, Australia.
    Wu PE; Taiwan Biobank, Institute of Biomedical Sciences, Academia Sinica, Taipei 115, Taiwan.
    Shen CY; Institute of Biomedical Sciences, Academia Sinica, Taipei 115, Taiwan.; School of Public Health, China Medical University, Taichung 404, Taiwan.
    Fasching PA; Department of Medicine Division of Hematology and Oncology, David Geffen School of Medicine, University of California, Los Angeles, CA 90095, USA.; Department of Gynecology and Obstetrics, Comprehensive Cancer Center ER-EMN, University Hospital Erlangen, Friedrich-Alexander-University Erlangen-Nuremberg, 91054 Erlangen, Germany.
    Ekici AB; Institute of Human Genetics, Comprehensive Cancer Center Erlangen-EMN, University Hospital Erlangen, Friedrich-Alexander University Erlangen-Nuremberg, 91054 Erlangen, Germany.
    Muir K; Division of Population Health, Health Services Research and Primary Care, School of Health Sciences, Faculty of Biology, Medicine and Health, The University of Manchester, Manchester M13 9PL, UK.
    Lophatananon A; Division of Population Health, Health Services Research and Primary Care, School of Health Sciences, Faculty of Biology, Medicine and Health, The University of Manchester, Manchester M13 9PL, UK.
    Brenner H; Division of Clinical Epidemiology and Aging Research, German Cancer Research Center (DKFZ), 69120 Heidelberg, Germany.; Division of Preventive Oncology, German Cancer Research Center (DKFZ) and National Center for Tumor Diseases (NCT), 69120 Heidelberg, Germany.; German Cancer Consortium (DKTK), German Cancer Research Center (DKFZ), 69120 Heidelberg, Germany.
    Arndt V; Division of Clinical Epidemiology and Aging Research, German Cancer Research Center (DKFZ), 69120 Heidelberg, Germany.
    Jones ME; Division of Genetics and Epidemiology, The Institute of Cancer Research, London SM2 5NG, UK.
    Swerdlow AJ; Division of Genetics and Epidemiology, The Institute of Cancer Research, London SM2 5NG, UK.; Division of Breast Cancer Research, The Institute of Cancer Research, London SW7 3RP, UK.
    Hoppe R; Dr. Margarete Fischer-Bosch-Institute of Clinical Pharmacology, 70376 Stuttgart, Germany.; University of Tübingen, 72074 Tübingen, Germany.
    Ko YD; Department of Internal Medicine, Evangelische Kliniken Bonn gGmbH, Johanniter Krankenhaus, 53177 Bonn, Germany.
    Hartman M; Saw Swee Hock School of Public Health, National University of Singapore and National University Health System, Singapore 117549, Singapore.; Department of Surgery, Yong Loo Lin School of Medicine, National University of Singapore and National University Health System, Singapore 119228, Singapore.; Department of Surgery, National University Health System, Singapore 119228, Singapore.
    Li J; Human Genetics Division, Genome Institute of Singapore, Singapore 138672, Singapore.
    Mannermaa A; Translational Cancer Research Area, University of Eastern Finland, 70210 Kuopio, Finland.; Institute of Clinical Medicine, Pathology and Forensic Medicine, University of Eastern Finland, 70210 Kuopio, Finland.; Biobank of Eastern Finland, Kuopio University Hospital, 70210 Kuopio, Finland.
    Hartikainen JM; Translational Cancer Research Area, University of Eastern Finland, 70210 Kuopio, Finland.; Institute of Clinical Medicine, Pathology and Forensic Medicine, University of Eastern Finland, 70210 Kuopio, Finland.
    Benitez J; Biomedical Network on Rare Diseases (CIBERER), 28029 Madrid, Spain.; Human Cancer Genetics Programme, Spanish National Cancer Research Centre (CNIO), 28029 Madrid, Spain.
    González-Neira A; Human Cancer Genetics Programme, Spanish National Cancer Research Centre (CNIO), 28029 Madrid, Spain.
    Haiman CA; Department of Preventive Medicine, Keck School of Medicine, University of Southern California, Los Angeles, CA 90033, USA.
    Dörk T; Gynaecology Research Unit, Hannover Medical School, 30625 Hannover, Germany.
    Bogdanova NV; Gynaecology Research Unit, Hannover Medical School, 30625 Hannover, Germany.; Department of Radiation Oncology, Hannover Medical School, 30625 Hannover, Germany.; NN Alexandrov Research Institute of Oncology and Medical Radiology, 223040 Minsk, Belarus.
    Teo SH; Breast Cancer Research Programme, Cancer Research Malaysia, Subang Jaya 47500, Malaysia.; Department of Surgery, Faculty of Medicine, University of Malaya, Kuala Lumpur 50603, Malaysia.
    Mohd Taib NA; Breast Cancer Research Unit, University Malaya Cancer Research Institute, Faculty of Medicine, University of Malaya, Kuala Lumpur 50603, Malaysia.
    Fletcher O; The Breast Cancer Now Toby Robins Research Centre, The Institute of Cancer Research, London SW7 3RP, UK.
    Johnson N; The Breast Cancer Now Toby Robins Research Centre, The Institute of Cancer Research, London SW7 3RP, UK.
    Grip M; Department of Surgery, Oulu University Hospital, University of Oulu, 90220 Oulu, Finland.
    Winqvist R; Laboratory of Cancer Genetics and Tumor Biology, Cancer and Translational Medicine Research Unit, Biocenter Oulu, University of Oulu, 90570 Oulu, Finland.; Laboratory of Cancer Genetics and Tumor Biology, Northern Finland Laboratory Centre Oulu, Oulu 90570, Finland.
    Blomqvist C; Department of Oncology, Helsinki University Hospital, University of Helsinki, 00290 Helsinki, Finland.; Department of Oncology, Örebro University Hospital, 70185 Örebro, Sweden.
    Nevanlinna H; Department of Obstetrics and Gynecology, Helsinki University Hospital, University of Helsinki, 00290 Helsinki, Finland.
    Lindblom A; Department of Molecular Medicine and Surgery, Karolinska Institutet, 171 76 Stockholm, Sweden.; Department of Clinical Genetics, Karolinska University Hospital, 171 76 Stockholm, Sweden.
    Wendt C; Department of Clinical Science and Education, Södersjukhuset, Karolinska Institutet, 118 83 Stockholm, Sweden.
    Kristensen VN; Department of Medical Genetics, Oslo University Hospital and University of Oslo, 0450 Oslo, Norway.; Institute of Clinical Medicine, Faculty of Medicine, University of Oslo, 0372 Oslo, Norway.
    Nbcs Collaborators; Department of Medical Genetics, Oslo University Hospital and University of Oslo, 0450 Oslo, Norway.; Institute of Clinical Medicine, Faculty of Medicine, University of Oslo, 0372 Oslo, Norway.; Department of Research, Vestre Viken Hospital, 3004 Drammen, Norway.; Department of Tumor Biology, Institute for Cancer Research, Oslo University Hospital, 0450 Oslo, Norway.; Department of Cancer Genetics, Institute for Cancer Research, Oslo University Hospital-Radiumhospitalet, 0450 Oslo, Norway.; Section for Breast- and Endocrine Surgery, Department of Cancer, Division of Surgery, Cancer and Transplantation Medicine, Oslo University Hospital-Ullevål, 0450 Oslo, Norway.; Department of Radiology and Nuclear Medicine, Oslo University Hospital, 0450 Oslo, Norway.; Department of Pathology at Akershus University Hospital, 1478 Lørenskog, Norway.; Department of Oncology, Division of Surgery and Cancer and Transplantation Medicine, University Hospital-Radiumhospitalet, 0405 Oslo, Norway.; National Advisory Unit on Late Effects after Cancer Treatment, Department of Oncology, Oslo University Hospital, 0405 Oslo, Norway.; Department of Oncology, Akershus University Hospital, 1478 Lørenskog, Norway.; Oslo Breast Cancer Research Consortium, Oslo University Hospital, 0405 Oslo, Norway.
    Tollenaar RAEM; Department of Surgery, Leiden University Medical Center, 2333 ZA Leiden, The Netherlands.
    Heemskerk-Gerritsen BAM; Department of Medical Oncology, Erasmus MC Cancer Institute, 3015 CN Rotterdam, The Netherlands.
    Radice P; Unit of Molecular Bases of Genetic Risk and Genetic Testing, Department of Research, Fondazione IRCCS Istituto Nazionale dei Tumori (INT), 20133 Milan, Italy.
    Bonanni B; Division of Cancer Prevention and Genetics, IEO, European Institute of Oncology IRCCS, 20141 Milan, Italy.
    Hamann U; Molecular Genetics of Breast Cancer, German Cancer Research Center (DKFZ), 69120 Heidelberg, Germany.
    Manoochehri M; Molecular Genetics of Breast Cancer, German Cancer Research Center (DKFZ), 69120 Heidelberg, Germany.
    Lacey JV; Department of Computational and Quantitative Medicine, City of Hope, Duarte, CA 91010, USA.; City of Hope Comprehensive Cancer Center, City of Hope, Duarte, CA 91010, USA.
    Martinez ME; Moores Cancer Center, University of California San Diego, La Jolla, CA 92037, USA.; Herbert Wertheim School of Public Health and Longevity Science, University of California San Diego, La Jolla, CA 92161, USA.
    Dunning AM; Centre for Cancer Genetic Epidemiology, Department of Oncology, University of Cambridge, Cambridge CB1 8RN, UK.
    Pharoah PDP; Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge CB2 0SR, UK.; Centre for Cancer Genetic Epidemiology, Department of Oncology, University of Cambridge, Cambridge CB1 8RN, UK.
    Easton DF; Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge CB2 0SR, UK.; Centre for Cancer Genetic Epidemiology, Department of Oncology, University of Cambridge, Cambridge CB1 8RN, UK.
    Yoo KY; Department of Preventive Medicine, Seoul National University College of Medicine, Seoul 03080, Korea.
    Kang D; Department of Biomedical Sciences, Seoul National University Graduate School, Seoul 03080, Korea.; Cancer Research Institute, Seoul National University, Seoul 03080, Korea.; Department of Preventive Medicine, Seoul National University College of Medicine, Seoul 03080, Korea.
    Pokaż więcej
    Źródło:
    Cancers [Cancers (Basel)] 2021 May 14; Vol. 13 (10). Date of Electronic Publication: 2021 May 14.
    Typ publikacji:
    Journal Article
    Czasopismo naukowe
    Pełny tekst  Link otwiera się w nowym oknieSzczegóły
    Tytuł:
    Long-Term Morbidity and Health After Early Menopause Due to Oophorectomy in Women at Increased Risk of Ovarian Cancer: Protocol for a Nationwide Cross-Sectional Study With Prospective Follow-Up (HARMOny Study).
    Autorzy:
    Terra L; Department of Psychosocial Research and Epidemiology, The Netherlands Cancer Institute, Amsterdam, Netherlands.
    Hooning MJ; Department of Medical Oncology, Erasmus University Medical Center, Rotterdam, Netherlands.
    Heemskerk-Gerritsen BAM; Department of Medical Oncology, Erasmus University Medical Center, Rotterdam, Netherlands.
    van Beurden M; Department of Gynaecology, Antoni van Leeuwenhoek, Amsterdam, Netherlands.
    Roeters van Lennep JE; Department of Internal Medicine, Erasmus University Medical Center, Rotterdam, Netherlands.
    van Doorn HC; Department for Gynaecologic Oncology, Erasmus University Medical Center, Rotterdam, Netherlands.
    de Hullu JA; Department for Gynaecology, Radboud University Medical Center, Nijmegen, Netherlands.
    Mom C; Department of Gynaecology, Amsterdam University Medical Centers, Amsterdam, Netherlands.
    van Dorst EBL; Department for Gynaecologic Oncology, University Medical Center Utrecht, Utrecht, Netherlands.
    Mourits MJE; Department for Gynaecologic Oncology, University Medical Center Groningen, University of Groningen, Groningen, Netherlands.
    Slangen BFM; Department for Gynaecology, Maastricht University Medical Center, Maastricht, Netherlands.
    Gaarenstroom KN; Department of Gynaecology, Leiden University Medical Center, Leiden, Netherlands.
    Zillikens MC; Department of Internal Medicine, Erasmus University Medical Center, Rotterdam, Netherlands.
    Leiner T; Department Radiology, University Medical Center Utrecht, Utrecht, Netherlands.
    van der Kolk L; Family Cancer Clinic, Netherlands Cancer Institute, Amsterdam, Netherlands.
    Collee M; Department for Clinical Genetics, Erasmus University Medical Center, Rotterdam, Netherlands.
    Wevers M; Department for Clinical Genetics, Radboud University Medical Center, Nijmegen, Netherlands.
    Ausems MGEM; Division of Laboratories, Pharmacy and Biomedical Genetics, Department of Genetics, University Medical Center Utrecht, Utrecht, Netherlands.
    van Engelen K; Department for Clinical Genetics, Amsterdam University Medical Centers, Vrije University Amsterdam, Amsterdam, Netherlands.
    Berger LP; Department of Genetics, University Medical Center Groningen, Groningen, Netherlands.
    van Asperen CJ; Department for Clinical Genetics, Leiden University Medical Center, Leiden, Netherlands.
    Gomez-Garcia EB; Department of Genetics, Maastricht University Medical Center, Maastricht, Netherlands.
    van de Beek I; Department for Clinical Genetics, Amsterdam University Medical Centers, University of Amsterdam, Amsterdam, Netherlands.
    Rookus MA; Department of Psychosocial Research and Epidemiology, The Netherlands Cancer Institute, Amsterdam, Netherlands.
    Hauptmann M; Brandenburg Medical School Theodor Fontane, Institute of Biostatistics and Registry Research, Neuruppin, Germany.
    Bleiker EM; Department of Psychosocial Research and Epidemiology, The Netherlands Cancer Institute, Amsterdam, Netherlands.
    Schagen SB; Department of Psychosocial Research and Epidemiology, The Netherlands Cancer Institute, Amsterdam, Netherlands.
    Aaronson NK; Department of Psychosocial Research and Epidemiology, The Netherlands Cancer Institute, Amsterdam, Netherlands.
    Maas AHEM; Department of Cardiology, Radboud University Medical Center, Nijmegen, Netherlands.
    van Leeuwen FE; Department of Psychosocial Research and Epidemiology, The Netherlands Cancer Institute, Amsterdam, Netherlands.
    Pokaż więcej
    Źródło:
    JMIR research protocols [JMIR Res Protoc] 2021 Jan 22; Vol. 10 (1), pp. e24414. Date of Electronic Publication: 2021 Jan 22.
    Typ publikacji:
    Journal Article
    Czasopismo naukowe
    Pełny tekstSzczegóły
    Tytuł:
    Long-term outcomes of bilateral direct-to-implant breast reconstruction in women at high breast cancer risk.
    Autorzy:
    van Verschuer VMT; a Department of Surgical Oncology , Erasmus MC Cancer Institute, University Medical Center Rotterdam , Rotterdam , the Netherlands.
    Mureau MAM; b Department of Plastic and Reconstructive Surgery , Erasmus MC Cancer Institute, University Medical Center Rotterdam , Rotterdam , the Netherlands.
    Heemskerk-Gerritsen BAM; c Department of Medical Oncology , Erasmus MC Cancer Institute, University Medical Center Rotterdam , Rotterdam , the Netherlands.
    Gadjradj PS; a Department of Surgical Oncology , Erasmus MC Cancer Institute, University Medical Center Rotterdam , Rotterdam , the Netherlands.
    Rogier C; a Department of Surgical Oncology , Erasmus MC Cancer Institute, University Medical Center Rotterdam , Rotterdam , the Netherlands.
    Verhoef C; a Department of Surgical Oncology , Erasmus MC Cancer Institute, University Medical Center Rotterdam , Rotterdam , the Netherlands.
    Gopie JP; d Center for Human and Clinical Genetics, Leiden University Medical Center , Leiden , the Netherlands.
    Seynaeve C; c Department of Medical Oncology , Erasmus MC Cancer Institute, University Medical Center Rotterdam , Rotterdam , the Netherlands.
    Koppert LB; a Department of Surgical Oncology , Erasmus MC Cancer Institute, University Medical Center Rotterdam , Rotterdam , the Netherlands.
    Pokaż więcej
    Źródło:
    Journal of plastic surgery and hand surgery [J Plast Surg Hand Surg] 2018 Aug; Vol. 52 (4), pp. 245-252. Date of Electronic Publication: 2018 May 28.
    Typ publikacji:
    Journal Article
    MeSH Terms:
    Breast Implantation*/adverse effects
    Breast Implants*
    Esthetics*
    Patient Satisfaction*
    Adult ; Breast Neoplasms/surgery ; Female ; Follow-Up Studies ; Humans ; Mastectomy, Subcutaneous ; Middle Aged ; Reoperation/statistics & numerical data ; Risk Factors ; Time-to-Treatment ; Young Adult
    Czasopismo naukowe
    Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
      Wyświetlanie 1-9 z 9

      Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies